Marico Increases Stake in PLIX Brand Owner Satiya Nutraceuticals to 84.09% for ₹1,012 Crore
Marico Limited acquired an additional 24.09% stake in Satiya Nutraceuticals (PLIX brand owner) for ₹1,012.03 Crores, increasing its total stake to 84.09%. The company plans to acquire the remaining 14.09% in July 2027. Satiya Nutraceuticals reported ₹864.31 Crores turnover in FY26.
The acquisition represents a substantial investment and a strategic expansion into new market segments, which is likely to have a significant impact on Marico's overall business and market position.
The acquisition of a significant stake in Satiya Nutraceuticals, a growing brand in the nutrition and personal care segment, is a positive strategic move for Marico Limited, indicating expansion and growth.
Marico Limited has announced an increase in its aggregate stake in Satiya Nutraceuticals Private Limited, the owner of the brand 'PLIX', from 60% to 84.09% on a fully diluted basis. This transaction involved acquiring an additional 24.09% stake from the Founders and certain other shareholders for a consideration of ₹1,012.03 Crores, completed on October 5, 2026.
The company also entered into definitive agreements to acquire a further 38.18% stake in Satiya Nutraceuticals. The current acquisition of 24.09% is part of this larger transaction. The acquisition is strategic, expanding Marico's presence in the value-added foods, nutrition, personal care, and wellness segments.
Satiya Nutraceuticals Private Limited, incorporated in 2020, is a Mumbai-based company known for its plant-based nutrition and personal care brand 'The Plant Fix – Plix'. The remaining 14.09% stake is planned to be acquired in July 2027, subject to terms and conditions, with a base consideration of up to ₹592 Crores plus additional milestone-based payments.
For FY26, Satiya Nutraceuticals reported a consolidated turnover of ₹864.31 Crores, compared to ₹432.84 Crores in FY25 and ₹155.32 Crores in FY24. The acquisition is structured as a cash consideration and is not expected to require any governmental or regulatory approvals. It is noted that the stake acquisition by Marico from the Founders constitutes related party transactions, conducted on an arm's length basis, with no interest from the Promoter/Promoter Group of Marico.
What to do with a filing like this
Marico Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Marico Limited. Read the original for the full detail.